Search

everythinglearnresearchcommunity

for

Search:↓

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

The research shows how certain drug molecules form stable structures with polymers, which could help create new drug forms.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Bifidobacterium longum BB536 metabolites may help treat hair loss by repairing and promoting hair cell growth.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Centipeda minima and brevilin A protect skin cells from damage and aging.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Activated protein C helps protect mice from long-term radiation damage.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

C4BPA protein may link acne severity and insulin resistance.

Increasing TSPO in the brain reduces anxiety and depression.

PTH-CBD helps reduce hair loss in mice by stimulating hair growth directly.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Progesterone affects GABA_A receptor function by altering δ subunit levels.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Certain alkaloids could help create new coronavirus drugs.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Neurosteroid withdrawal increases α4 subunit expression in the hippocampus, which may relate to catamenial epilepsy in women.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.